small molecule

FLUXID

FAMOTIDINE

Loss of exclusivity—loss of exclusivity

CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand name	FLUXID
Active ingredient	FAMOTIDINE
Strength	40MG
Dosage form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Modality	Small molecule
FDA approval	September 2004
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.